Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02902107 · ClinicalTrials.gov registry record · Phase 1
Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet
A Phase 1 study of Pelvic Malignancy and Abdominal Malignancy, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT02902107: Completed Phase 1 study of Pelvic Malignancy and Abdominal Malignancy, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02902107 is a Phase 1 study of Pelvic Malignancy and Abdominal Malignancy that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02902107, a Phase 1 study of Pelvic Malignancy and Abdominal Malignancy, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a pilot study of the CivaSheet, a new type of intraoperative radiation therapy (IORT) device that offers several advantages over existing techniques of performing IORT. The CivaSheet device in this study is already approved by the FDA and is not an experimental device. This study will allow us to determine how feasible it is to implant the CivaSheet into patients undergoing surgery for abdominal and pelvic tumors, and assess any possible side effects of the device. This study, if successful, may allow us to offer the CivaSheet more widely as treatment option to future patients.
Conditions Studied
Interventions
- RADIATION Brachytherapy
- DEVICE CivaSheet
- PROCEDURE surgical resection
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-09-09 |
| Est. Completion | 2024-10-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02902107
The ClinicalTrials.gov registry entry for NCT02902107 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pelvic Malignancy appearing as the primary indexed condition, and to 3 interventions - of which Brachytherapy is the first listed.
NCT02902107 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02902107 about?
NCT02902107 is a clinical study titled "Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet". This study is a pilot study of the CivaSheet, a new type of intraoperative radiation therapy (IORT) device that offers several advantages over existing techniques of performing IORT. The CivaSheet device in this study is already approved by the FDA and is not an experimental device. This study will ...
What is the current status of trial NCT02902107?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2016-09-09. Estimated completion is 2024-10-17.
What conditions does trial NCT02902107 study?
This clinical trial studies the following conditions: Pelvic Malignancy, Abdominal Malignancy.
What interventions are being tested in trial NCT02902107?
The interventions under investigation include: Brachytherapy (RADIATION), CivaSheet (DEVICE), surgical resection (PROCEDURE).
Who is sponsoring clinical trial NCT02902107?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02902107 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Malignancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.